Pathophysiology

•synonyms: cartilaginous exostosis, osteochondromatosis, diaphyseal aclasia, and hereditary exostosis

•multiple cartilaginous exostoses is a developmental condition of growing dogs

•2 forms: single (= osteochondroma) or multicentric (= osteochondromatosis)

•breed predisposition: Alaskan Malamute (± hereditary) and Terriers

•pathogenesis is unknown but possibilities include:

•fragments of the epiphyseal plate are pinched off and grow independently

•aberrant activity (i.e., cartilaginous metaplasia) of the osteogenic layer of the periosteum

•defect in the perichondral ring, bone growth, and remodeling

•physeal dysplasia

•incidence is difficult to determine as many dogs are asymptomatic

•lesions arise from areas of endochondral ossification where new bone is formed on cartilage caps (i.e., metaphysis)

•lesions can occur in the appendicular and axial skeleton and trachea

•lesions start in the metaphyseal region but move away from the physis with longitudinal bone growth

•large lesions can cause remodeling of adjacent bone

•lesions stop growing at skeletal maturity and they usually remain as unchanged mature bony projections

•30% lesions are observed < 3 months, 39% between 3-13 months, and 30% > 13 months

•malignant transformation to OSA or CSA has been reported in 6 dogs with multiple cartilaginous exostoses (4 with metastases) and 2 dogs with solitary spinal osteochondromas

•majority of dogs with metastatic transformation have persistent cartilaginous caps on their apical margins

•chondrosarcomatous transformation is reported in 1%-5% of humans with solitary osteochondromas and 10%-25% with multiple cartilaginous exostoses

•malignant potential is related to the thickness of the apical cap on MRI


Clinical Signs

•common sites: vertebrae, ribs, and long bones

•no clinical significance unless lesion interferes with joint movement, compresses vital structures (i.e., spinal cord, nerves, blood vessels, or trachea), or undergoes malignant transformation

•multiple sites of spinal cord compression is common

•palpable masses are variably painful due to mechanical irritation from overlying soft tissues


Diagnosis


Survey Radiographs

•bony mass with a fine trabecular on the surface of the affected bone with no evidence of bony lysis or proliferation and the cortex is smooth ± thin and medullary cavity is contiguous with host bone

•bilateral and often located on the outer cortical surface adjacent to the metaphysis ± diaphysis but not the epiphysis

•eccentric outgrowths of radiodense cancellous bone with regular contours merging into the parent bone

•vertebral and rib exostoses are usually circular with a sessile base while appendicular exostoses are varied

•exostoses are covered by a cap of radiolucent cartilage which may later calcify and become radiodense

•malignant transformation is characterized by indistinct, poorly mineralized, irregular, and thickened cartilage cap (CSA > 2-3 cm) which may require CT or MRI for diagnosis


Histology

•histologic diagnosis requires biopsy of the cartilaginous cap and underlying bony stalk

•histologic features include cartilaginous cap giving rise to an array of maturing bone according to the sequence of endochondral ossification with the cortical bone surface and surface of the mass continuous


Treatment

•conservative surgical resection is recommended if clinical signs do not abate following skeletal maturity


Prognosis

•38% mortality rate < 12 months due to progression of clinical signs

•malignant transformation in up to 83% (5/6) dogs with a single osteochondroma surviving > 6 years

SURGICAL ONCOLOGY

SOCIETY

RESEARCH

EDUCATION

LINKS

EMPLOYMENT

 IMAGE LIBRARYImages.html
● HistoryHistory.html
● What is a Surgical OncologistSurgical_Oncology_1.html
● Find a Surgical OncologistSurgical_Oncology_2.html
● Aims and ObjectivesAims.html
● MembershipMembership.html
● CommitteesCommittees.html
● NewsletterNewsletter.html
● Constitution and BylawsConstitution.html
● Research TrialsResearch_Trials.html
● Publications by MembersPublications.html
● Research OpportunitiesResearch_Opportunities.html
● Cancer InformationCancer_Information_1.html
● Conferences and MeetingsConferences.html
● Radiation FacilitiesRadiation_Facilities.html
● CE OpportunitiesCE_Opportunities.html
● Cancer InformationCancer_Information_2.html
● Current OpportunitiesEmployment_Opportunities.html
● Fellowship Training GuidelinesFellowship_Guidelines.html

OSTEOCHONDROMA AND MULTIPLE CARTILAGINOUS EXOSTOSIS

● Surgical Oncology JournalsJournals.html
● Surgical Oncology SocietiesSocieties.html
● Veterinary Surgery CollegesColleges.html

Interpretation

Cortisol Level

Normal

250-450 nmol/L

Pituitary- or adrenal-dependent hyperadrenocorticism

> 600 nmol/L

Iatrogenic hyperadrenocorticism

< 150 nmol/L

Interpretation

3 Hours

Normal

< 40 nmol/L

Pituitary-dependent hyperadrenocorticism

< 40 nmol/L

Pituitary- or adrenal-dependent hyperadrenocorticism

> 40 nmol/L

8 Hours

< 40 nmol/L

> 40 nmol/L

> 40 nmol/L

Diagnostic Test

Sensitivity

Specificity

Accuracy

LDDST

85%-100%

44%-73%

58%-92%

ACTH Stimulation

80%-95%

82%-91%

84%-93%

Urine Cortisol-to-Creatinine

50%-100%

22%-100%

37%-91%

Interpretation

Cortisol Level

Pituitary-dependent hyperadrenocorticism

< 50% T0 cortisol concentration

Pituitary- or adrenal-dependent hyperadrenocorticism

> 50% T 0 cortisol concentration

Interpretation

Cortisol Level

Normal

37-80 ng/L

Pituitary-dependent hyperadrenocorticism

> 75 ng/L

Adrenal-dependent hyperadrenocorticism

< 37 ng/L